BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33534409)

  • 41. Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
    Li A; Li J; Austin RM; Wang T; Ashman D; Zhang H; Matsko J; Zhao C
    Cancer Cytopathol; 2021 Aug; 129(8):622-631. PubMed ID: 33764649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M; Zhao C
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study.
    Feldstein O; Gali-Zamir H; Schejter E; Feinberg T; Yehuda-Shnaidman E; Bornstein J; Levy T
    Acta Obstet Gynecol Scand; 2023 Feb; 102(2):226-233. PubMed ID: 36478537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya.
    Ting J; Mugo N; Kwatampora J; Hill C; Chitwa M; Patel S; Gakure H; Kimani J; Schoenbach VJ; Poole C; Smith JS
    Sex Transm Dis; 2013 Jul; 40(7):584-9. PubMed ID: 23965776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and Clearance of Anal High-risk Human Papillomavirus Infections and Their Determinants Over 5 Years Among Human Immunodeficiency Virus-negative Men Who Have Sex With Men.
    Marra E; Kovaleva A; Bruisten SM; Vermeulen W; Boyd A; Schim van der Loeff MF
    Clin Infect Dis; 2019 Apr; 68(9):1556-1565. PubMed ID: 30169621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevalence of oncogenic human papillomavirus in patients with cervical lesion].
    Juárez-González K; Paredes-Cervantes V; Martínez-Salazar M; Gordillo-Rodríguez S; Vera-Arzave C; Martínez-Meraz M; Sánchez-Suárez P; Vázquez-Vega S
    Rev Med Inst Mex Seguro Soc; 2020 May; 58(3):243-249. PubMed ID: 34002982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
    Ferré VM; Ekouevi DK; Gbeasor-Komlanvi FA; Collin G; Le Hingrat Q; Tchounga B; Salou M; Descamps D; Charpentier C; Dagnra AC
    Clin Microbiol Infect; 2019 Dec; 25(12):1560.e1-1560.e7. PubMed ID: 31051265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
    Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
    Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
    Aromseree S; Wongjumpa W; Ekalaksananan T; Temtanakitpaisan A; Kleebkaow P; Srisathaporn S; Tongchai P; Pientong C
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3405-3411. PubMed ID: 36308365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital.
    Thistle P; Parpia R; Pain D; Lee H; Manasa J; Schnipper LE
    JCO Glob Oncol; 2020 Aug; 6():1276-1281. PubMed ID: 32783640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
    BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytology, High-Risk Human Papillomavirus Testing and Serum CA19-9 in a Large Cohort of Patients with Invasive Cervical Adenocarcinomas: Correlation with a New Pathogenetic Classification.
    Shi H; Ma Y; Shao Y; Zhang Y; Lu B
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2599-2605. PubMed ID: 36037112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
    van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG
    Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
    Najioullah F; Dorival MJ; Joachim C; Dispagne C; Macni J; Abel S; Sulpicy C; Charpentier-Baltide H; Sainte-Rose D; Salomon-Frechou B; Dieye M; Véronique-Baudin J; Pré M; Marquet M; Wan-Ajouhu G; Janky E; Riethmuller D; Cesaire R;
    PLoS One; 2021; 16(10):e0257915. PubMed ID: 34618835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Prevalence of High-Risk Human Papillomavirus in Hungary-A Geographically Representative, Cross-Sectional Study.
    Fogarasi AI; Benczik M; Moravcsik-Kornyicki Á; Kocsis A; Gyulai A; Kósa Z
    Pathol Oncol Res; 2022; 28():1610424. PubMed ID: 35783359
    [No Abstract]   [Full Text] [Related]  

  • 57. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
    Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anal Human Papillomavirus Infection in Kidney Transplant Recipients Compared With Immunocompetent Controls.
    Larsen HK; Kjaer SK; Haedersdal M; Kjaer AK; Bonde JH; Sørensen SS; Thomsen LT
    Clin Infect Dis; 2022 Nov; 75(11):1993-1999. PubMed ID: 35438132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative performance of the human papillomavirus test and cytology for primary screening for high-grade cervical intraepithelial neoplasia at the population level.
    Hurtado-Salgado E; Cárdenas-Cárdenas L; Salmerón J; Luna-Gordillo R; Ortiz-Panozo E; Allen-Leigh B; Saavedra-Lara N; Franco EL; Lazcano-Ponce E
    Int J Cancer; 2022 May; 150(9):1422-1430. PubMed ID: 34921727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sexual Mixing Patterns and Anal Human Papillomavirus Among Young Gay, Bisexual, and Other Men Who Have Sex With Men and Transgender Women in 2 Cities in the United States, 2012-2014.
    Assaf RD; Javanbakht M; Meites E; Gratzer B; Steinau M; Crosby RA; Markowitz LE; Unger ER; Gorbach PM
    Sex Transm Dis; 2020 Jul; 47(7):473-480. PubMed ID: 32541306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.